Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study
Journal of Medical Internet Research · 2026
DOI: 10.2196/78337 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Journal of Medical Internet Research, 2026. Verfasst von Zengxia Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Mindfulness, Chemoembolization, Therapeutic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) experience significant psychological distress, impacting outcomes. While mindfulness-based interventions (MBIs) are beneficial, access is limited. Internet-delivered MBIs (iMBIs) offer an accessible alternative; yet, qualitative understanding of patient experiences with tailored iMBIs for this specific population is lacking.
Objective
This study aimed to explore the facilitators and barriers of patients with HCC post TACE and participated in tailored iMBIs.
Methods
From November 2020 to December 2022, 11 patients with HCC post TACE who had taken part in tailored iMBIs were purposively recruited from a tertiary hospital in Jilin Province. Data were collected through semistructured interviews lasting 30-60 minutes. The interviews were analyzed using conventional content analysis.
Results
Five main categories emerged from the analysis: (1) mindfulness mindset, including acceptance, calmness, and mood improvement; (2) improvement of physical discomfort, such as better sleep, pain relief, reduced gastrointestinal symptoms, and increased activity levels; (3) resistance to mindfulness practice, including perceived lack of effectiveness, unsuitable conditions, equipment limitations, and difficulty concentrating; (4) support and encouragement, involving social support, supervision, and professional guidance; and (5) accessibility and convenience characterized by restoration of life balance and user-friendly features of the practice. Each category encompassed several subcategories reflecting the diverse experiences of participants.
Conclusions
While iMBIs were generally perceived as convenient and accessible, challenges such as equipment limitations were noted. Future implementation should focus on enhancing supportive factors to improve adherence, minimizing barriers, and refining the design and delivery of iMBI programs. Trial Registration Chinese Clinical Trial Registry ChiCTR1900027976; https://www.chictr.org.cn/showproj.html?proj=46657
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Anhui Medical University, Hefei, China.
- Department of Nursing, First Affiliated Hospital of Anhui Medical University, Hefei, China.
- School of Nursing, Jilin University, Changchun, Jilin, China.
- Department of Intervention, First Hospital of Jilin University, Changchun, China.
ORCID-Profile: Zengxia Liu, Min Li, Yong Jia, Li Chen
Zitieren
APA
Liu, Z., Li, M., Jia, Y., & Chen, L. (2026). Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study. Journal of Medical Internet Research. https://doi.org/10.2196/78337
Vancouver
Liu Z, Li M, Jia Y, Chen L. Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study. Journal of Medical Internet Research. 2026. doi:10.2196/78337
BibTeX
@article{Liu2026,
author = {Liu, Zengxia and Li, Min and Jia, Yong and Chen, Li},
title = {Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study},
journal = {Journal of Medical Internet Research},
year = {2026},
doi = {10.2196/78337}
}
EUVIMED